Compare · AVR vs ISRG
AVR vs ISRG
Side-by-side comparison of Anteris Technologies Global Corp. (AVR) and Intuitive Surgical Inc. (ISRG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AVR and ISRG operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ISRG is the larger of the two at $162.13B, about 262.2x AVR ($618.4M).
- Over the past year, AVR is up 56.7% and ISRG is down 13.9% - AVR leads by 70.6 points.
- ISRG has been more active in the news (15 items in the past 4 weeks vs 5 for AVR).
- ISRG has more recent analyst coverage (25 ratings vs 6 for AVR).
- Company
- Anteris Technologies Global Corp.
- Intuitive Surgical Inc.
- Price
- $6.36+3.33%
- $457.85-0.03%
- Market cap
- $618.4M
- $162.13B
- 1M return
- +19.55%
- -1.43%
- 1Y return
- +56.65%
- -13.92%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2024
- 2000
- News (4w)
- 5
- 15
- Recent ratings
- 6
- 25
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Latest AVR
- SEC Form 424B3 filed by Anteris Technologies Global Corp.
- Anteris Technologies Global Corp. filed SEC Form 8-K: Termination of a Material Definitive Agreement
- Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial
- SEC Form 424B3 filed by Anteris Technologies Global Corp.
- Anteris Technologies Global Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement
- SEC Form 424B3 filed by Anteris Technologies Global Corp.
- SEC Form EFFECT filed by Anteris Technologies Global Corp.
- Cantor Fitzgerald resumed coverage on Anteris Technologies Global Corp. with a new price target
- Wells Fargo initiated coverage on Anteris Technologies Global Corp. with a new price target
- SEC Form POS AM filed by Anteris Technologies Global Corp.
Latest ISRG
- SEC Form 4 filed by Director Guthart Gary S
- Director Reed Monica P converted options into 531 shares, increasing direct ownership by 23% to 2,876 units (SEC Form 4)
- Director Nachtsheim Jami K converted options into 531 shares, increasing direct ownership by 8% to 6,902 units (SEC Form 4)
- Director Leonard Keith R converted options into 531 shares, increasing direct ownership by 144% to 901 units (SEC Form 4)
- Director Ladd Amy L converted options into 531 shares, increasing direct ownership by 442% to 651 units (SEC Form 4)
- Director Kolli Sreelakshmi converted options into 531 shares, increasing direct ownership by 54% to 1,510 units (SEC Form 4)
- Director Johnson Amal M converted options into 531 shares, increasing direct ownership by 4% to 13,545 units (SEC Form 4)
- Director Chew Lewis converted options into 531 shares, increasing direct ownership by 68% to 1,314 units (SEC Form 4)
- Director Beery Joseph C converted options into 531 shares, increasing direct ownership by 17% to 3,641 units (SEC Form 4)
- Director Barratt Craig H converted options into 750 shares (SEC Form 4)